Molecular Profiling as a Novel Tool to Predict Response to Interferon-Α2 in MPNs: The Proof of Concept in Early Myelofibrosis
Cancer - United States
doi 10.1002/cncr.30676
Full Text
Open PDFAbstract
Available in full text
Date
May 18, 2017
Authors
Publisher
Wiley